SCP Vitalife Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5

- Investments
-
40
- Portfolio
-
5
- Exits
-
30

SCP Vitalife Partners General Information
Description
Founded in 2002, SCP Vitalife Partners is a venture capital investment firm focused on life science investments in Israel and the United States. The firm seeks to invests in companies operating in the pharmaceuticals and drug delivery, bio-material, diagnostic and healthcare service sectors.
Contact Information
Website
www.scpvitalife.com
Year Founded
2002
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 15 Hatidhar Street
- P.O Box 2138
- Raanana 4366517
- Israel
+972 00-000-0000
SCP Vitalife Partners Investments (40)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Regentis Biomaterials | 05-Feb-2016 | Later Stage VC | 0000 | Therapeutic Devices | Generating Revenue | 0000 00000 |
000000 | 01-Sep-2015 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | |
0000000 0000000 00 | 30-Jun-2015 | 00000 00000 | 000.00 | Diagnostic Equipment | Out of Business | 0000000 0000000000 00 |
00000000 0000 | 07-Mar-2014 | 000 | 0000 | Pharmaceuticals | Generating Revenue/Not Profitable | 00000 0000000 00 |
0000000 0000000 00 | 27-Jan-2014 | 00000 00000 | 00.000 | Diagnostic Equipment | Out of Business | 0000000 0000000000 00 |
00000000 0000000 | 11-Nov-2013 | 00000 00000 | 0000 | Monitoring Equipment | Generating Revenue | 0000000 0000000000 00 |
000000 00000000 | 14-Jun-2013 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue/Not Profitable | 00000 0000000 00 |
000000 | 05-Mar-2013 | 00000 00000 | 0000 | Pharmaceuticals | Profitable | 0000 00000 |
Regentis Biomaterials | 14-May-2012 | Later Stage VC | 000.00 | Therapeutic Devices | Generating Revenue | 0000 00000 |
Avedro | 17-Feb-2012 | Later Stage VC | 000.00 | Pharmaceuticals | Profitable | 0000 00000 |
SCP Vitalife Partners Exits (30)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Ivenix | 03-May-2022 | Merger/Acquisition | 00000 |
000000 | 01-Jun-2021 | 000000000 00000000 | |
00000000 | 01-Sep-2019 | 000000000000000000 | 00000 |
0000 0000000 | 01-Aug-2019 | 000 00 00000000 | |
000 000000000000 | 01-Apr-2019 | 000 00 00000000 | |
000000 | 14-Feb-2019 | 000 | 0000 |
000000 00000000 | 16-Nov-2018 | 000000 0000000000 | 00.000 |
0000000 0000000 00 | 23-Sep-2018 | 000000000000000000 | 0000 |
BioControl Medical | 01-Feb-2017 | Out of Business | |
Societal CDMO | 14-Dec-2016 | Public Investment 2nd Offering | 0000 |
SCP Vitalife Partners Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
SCP Vitalife Partners Investments by Industry, Year, and Region
SCP Vitalife Partners Team (15)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Jeff Dykan | Managing Partner | 0 | 0 | 0 | Raanana, Israel |
Edna Charlap | Venture Partner | Raanana, Israel | |||
Edna Ludomirski | Venture Partner | Raanana, Israel | |||
Abraham Ludomirski MD | Partner | 0 | 0 | 0 | Raanana, Israel |
Dennis Ferry | Chief Financial Officer | 0 | Malvern, PA |